---
document_datetime: 2024-11-27 10:17:36
document_pages: 16
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/vaniqa-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: vaniqa-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 8.5876704
conversion_datetime: 2025-12-24 18:21:43.454077
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Vaniqa

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                        | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|--------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IA/0060              | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure | 05/11/2024                          | n/a                                         |                                  |           |
| N/0059               | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)             | 29/10/2024                          |                                             | PL                               |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| PSUSA/1202/ 202307   | Periodic Safety Update EU Single assessment - eflornithine (topical use)                                                                                           | 07/03/2024   | n/a        |                                  | PRAC Recommendation - maintenance   |
|----------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|-------------------------------------|
| N/0057               | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                   | 26/09/2022   |            | PL                               |                                     |
| II/0056              | B.I.z - Quality change - Active substance - Other variation                                                                                                        | 22/09/2022   | n/a        |                                  |                                     |
| IB/0055              | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                     | 27/10/2021   | 29/09/2022 | SmPC, Annex II, Labelling and PL |                                     |
| IA/0054              | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                      | 31/05/2021   | n/a        |                                  |                                     |
| PSUSA/1202/ 201807   | Periodic Safety Update EU Single assessment - eflornithine (topical use)                                                                                           | 14/03/2019   | n/a        |                                  | PRAC Recommendation - maintenance   |
| N/0053               | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                   | 06/03/2019   | 29/09/2022 | PL                               |                                     |
| II/0051              | B.I.a.1.b - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Introduction of a manufacturer of the AS supported by an ASMF | 19/07/2018   | n/a        |                                  |                                     |
| IB/0050              | B.II.f.1.z - Stability of FP - Change in the shelf-life or storage conditions of the finished product - Other variation                                            | 05/04/2017   | 16/03/2018 | SmPC, Annex II, Labelling and PL |                                     |

<div style=\"page-break-after: always\"></div>

| IB/0048/G   | This was an application for a group of variations. B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an ASMF B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an ASMF B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an ASMF B.I.a.4.b - Change to in-process tests or limits applied during the manufacture of the AS - Addition of a new in-process test and limits B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting   | 17/05/2016   | n/a        |    | material/intermediate   |
|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----|-------------------------|
| N/0049      | Update of the package leaflet with revised contact details of the local representative for Belgium. In addition, the MAH took the opportunity to make minor linguistic and editorial amendments in the package leaflets for some of the EEA languages (BG, DE, EL, FI, FR, IS, IT, LT, LV, NO and PL). Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 12/04/2016   | 16/03/2018 | PL |                         |

<div style=\"page-break-after: always\"></div>

| PSUSA/1202/ 201507   | Periodic Safety Update EU Single assessment - eflornithine (topical use)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 17/03/2016   | n/a        |             | PRAC Recommendation - maintenance   |
|----------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-------------|-------------------------------------|
| IAIN/0046            | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 11/07/2014   | 08/07/2015 | SmPC and PL |                                     |
| IB/0045/G            | This was an application for a group of variations. B.I.a.3.a - Change in batch size (including batch size ranges) of AS or intermediate - Up to 10-fold increase compared to the originally approved batch size B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an ASMF B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an ASMF B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an ASMF B.I.a.4.b - Change to in-process tests or limits applied during the manufacture of the AS - Addition of a new in-process test and limits B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure | 08/05/2014   | n/a        |             |                                     |

<div style=\"page-break-after: always\"></div>

| N/0044    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 09/04/2014   | 22/05/2014   | PL   |              |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|------|--------------|
| IAIN/0043 | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                                                                                                                                                                                                                                                                                                                         | 19/12/2013   | n/a          |      |              |
| IA/0042   | B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                                                                                                                                                                     | 25/09/2013   | n/a          |      |              |
| IAIN/0041 | B.I.a.1.a - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - The proposed manufacturer is part of the same pharmaceutical group as the currently approved                                                                                                                                                                                                                                                                                                                                                       | 13/08/2013   | n/a          |      | manufacturer |
| IB/0040/G | This was an application for a group of variations. B.I.a.1.a - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - The proposed manufacturer is part of the same pharmaceutical group as the currently approved manufacturer B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.2.e - Changes in the manufacturing process of | 18/07/2013   | n/a          |      |              |

<div style=\"page-break-after: always\"></div>

| the AS - Minor change ASMF B.I.b.1.b - Change in and/or limits of an AS, material/intermediate/reagent specification limits B.I.b.2.a - Change in starting material/reagent/intermediate changes to an approved B.I.b.2.a - Change in starting material/reagent/intermediate changes to an approved B.I.b.2.a - Change in starting material/reagent/intermediate changes to an approved B.I.d.1.a.4 - Stability period/storage period re-test period/storage data B.I.b.1.d - Change in and/or limits of an AS, material/intermediate/reagent significant specification an obsolete parameter) B.I.b.1.d - Change in and/or limits of an AS, material/intermediate/reagent significant specification an obsolete parameter) B.I.b.1.d - Change in of an AS,   | and/or limits   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------|

<div style=\"page-break-after: always\"></div>

<!-- image -->

|           | significant specification parameter (e.g. deletion of an obsolete parameter) B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |            |            |     |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----|
| II/0035/G | This was an application for a group of variations. Change in the specifications of the finished product. B.II.d.1.c - Change in the specification parameters and/or limits of the finished product - Addition of a new specification parameter to the specification with its corresponding test method B.II.d.1.c - Change in the specification parameters and/or limits of the finished product - Addition of a new specification parameter to the specification with its corresponding test method B.II.d.1.c - Change in the specification parameters and/or limits of the finished product - Addition of a new specification parameter to the specification with its corresponding test method B.II.d.1.c - Change in the specification parameters and/or limits of the finished product - Addition of a new specification parameter to the specification with its corresponding test method B.II.d.1.c - Change in the specification parameters and/or limits of the finished product - Addition of a new specification parameter to the specification with | 25/04/2013 | 25/04/2013 | its |

<div style=\"page-break-after: always\"></div>

|           | in the specification parameters and/or limits of the finished product - Addition of a new specification parameter to the specification with its corresponding test method B.II.d.1.e - Change in the specification parameters and/or limits of the finished product - Change outside the approved specifications limits range B.II.d.1.e - Change in the specification parameters and/or limits of the finished product - Change outside the approved specifications limits range   |            |            |                        | B.II.d.1.c - Change   |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------------------|
| IB/0038   | Update of the SmPC, labelling and the package leaflet according to the latest QRD template. The MAH also took the opportunity to amend an incorrect statement regarding age range introduced at the time of the latest renewal and to update the contact details of the local representatives for the United Kingdom, Ireland, the Netherlands and Italy. C.I.z - Changes (Safety/Efficacy) of Human and                                                                            | 10/04/2013 | 22/05/2014 | SmPC, Labelling and PL | Veterinary Medicinal  |
| IB/0036/G | This was an application for a group of variations. B.II.b.5.a - Change to in-process tests or limits applied during the manufacture of the finished product - Tightening of in-process limits B.II.b.3.z - Change in the manufacturing process of the finished product - Other variation                                                                                                                                                                                            | 22/03/2013 | n/a        |                        |                       |
| IA/0039/G | This was an application for a group of variations.                                                                                                                                                                                                                                                                                                                                                                                                                                  | 18/03/2013 | n/a        |                        |                       |

<div style=\"page-break-after: always\"></div>

<!-- image -->

| B.II.c.1.b - Change and/or limits of an specification corresponding test B.II.c.1.b - Change and/or limits of an specification corresponding test B.II.c.1.b - Change and/or limits of an specification corresponding test B.II.c.1.b - Change and/or limits of an specification corresponding test B.II.c.1.b - Change and/or limits of an specification corresponding test B.II.c.1.b - Change and/or limits of an specification corresponding test B.II.c.1.b - Change and/or limits of an specification corresponding test B.II.c.1.b - Change and/or limits of an specification   | in the excipient parameter to method in the excipient parameter to method in the excipient parameter to method in the excipient parameter to method in the excipient parameter to method in the excipient parameter to method in the excipient parameter to method in the excipient parameter to   |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

<!-- image -->

|           | B.II.c.1.b - Change in the specification parameters and/or limits of an excipient - Addition of a new specification parameter to the specification with its corresponding test method B.III.2.a.2 - Change of specification(s) of a former non Pharmacopoeial substance to comply with the Ph. Eur. or with a national pharmacopoeia of a Member State - Excipient/AS starting material                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |            |     |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| IA/0037/G | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites A.7 - Administrative change - Deletion of manufacturing sites B.II.c.1.b - Change in the specification parameters and/or limits of an excipient - Addition of a new specification parameter to the specification with its corresponding test method B.III.2.a.2 - Change of specification(s) of a former non Pharmacopoeial substance to comply with the Ph. Eur. or with a national pharmacopoeia of a Member State - Excipient/AS starting material B.II.c.1.a - Change in the specification parameters and/or limits of an excipient - Tightening of specification limits B.II.c.1.b - Change in the specification parameters and/or limits of an excipient - Addition of a new specification parameter to the specification with its corresponding test method B.II.c.2.a - Change in test procedure for an excipient | 06/03/2013 | n/a |

<div style=\"page-break-after: always\"></div>

| R/0034   | Renewal of the marketing authorisation.                                                     | 16/12/2010   | 04/03/2011   | SmPC, Annex II, Labelling and PL   | Based on the CHMP review of the available information and on the basis of a re-evaluation of the benefit risk balance, the CHMP is of the opinion that the quality, safety and efficacy of Vaniqa continues to be adequately and sufficiently demonstrated and therefore considered that the benefit risk profile of Vaniqa continues to be favourable.   |
|----------|---------------------------------------------------------------------------------------------|--------------|--------------|------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0033  | A.1 - Administrative change - Change in the name and/or address of the MAH                  | 30/09/2010   | n/a          | SmPC, Labelling and PL             |                                                                                                                                                                                                                                                                                                                                                           |
| IB/0032  | IB_33_Minor change in the manufacture of the finished product                               | 25/11/2009   | n/a          | SmPC, Labelling and PL             |                                                                                                                                                                                                                                                                                                                                                           |
| IB/0031  | IB_31_b_Change to in-process tests/limits during manufacture - addition of new tests/limits | 25/11/2009   | n/a          |                                    |                                                                                                                                                                                                                                                                                                                                                           |
| IA/0030  | IA_09_Deletion of manufacturing site                                                        | 14/08/2009   | n/a          | Annex II and PL                    |                                                                                                                                                                                                                                                                                                                                                           |
| IA/0029  | IA_05_Change in the name and/or address of a manufacturer of the finished product           | 14/08/2009   | n/a          | Annex II and PL                    |                                                                                                                                                                                                                                                                                                                                                           |
| T/0028   | Transfer of Marketing Authorisation                                                         | 13/05/2008   | 06/06/2008   | SmPC, Labelling and PL             |                                                                                                                                                                                                                                                                                                                                                           |
| IA/0027  | IA_09_Deletion of manufacturing site                                                        | 08/11/2007   | n/a          |                                    |                                                                                                                                                                                                                                                                                                                                                           |
| II/0026  | Update of Summary of Product Characteristics and Package Leaflet                            | 24/05/2007   | 27/06/2007   | SmPC and PL                        | Following the assessment of the Periodic Safety Update Report 9 covering the period 27 October 2005 -26 July 2006, the CHMP endorsed the MAH's proposal to replace                                                                                                                                                                                        |

<div style=\"page-break-after: always\"></div>

|         | Update of Summary of Product Characteristics and Package Leaflet                                 |            |            |                                  | the term 'hair disorder' with the more descriptive terms 'abnormal hair texture and abnormal hair growth' in Section 4.8 of the SPC and Section 4 of the PL.                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|---------|--------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| N/0025  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification) | 23/05/2007 | n/a        | PL                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| IB/0024 | IB_37_a_Change in the specification of the finished product - tightening of specification limits | 07/12/2006 | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| IB/0023 | IB_29_a_Change in qual./quant. composition of immediate packaging - semi-solid/liquid ph. forms  | 09/11/2006 | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| IB/0022 | IB_33_Minor change in the manufacture of the finished product                                    | 28/09/2006 | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| IB/0021 | IB_18_Replacement of an excipient with a comparable excipient                                    | 28/06/2006 | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| R/0020  | Renewal of the marketing authorisation.                                                          | 23/02/2006 | 18/04/2006 | SmPC, Annex II, Labelling and PL | Based on the review of the available information, the CHMP was of the opinion that the quality, the safety and the efficacy of Vaniqa continues to be adequately and sufficiently demonstrated and that the benefit/risk profile of Vaniqa continues to be favourable in the treatment of facial hirsutism in women. However the CHMP has concerns regarding the Phamacovigilance monitoring of Vaniqa by the MAH, in particular related to the low level of reporting of adverse events, the incorrect classification of such events according to System Organ Class and the methodology used to |

<div style=\"page-break-after: always\"></div>

|         |                                                                                   |            |     | Although the overall risk/benefit remains positive, due to the limited exposure of the product (marketed since August 2004), and the above-mentioned Pharmacovigilance concerns, the CHMP is of the opinion that one additional renewal is required. Based on the CHMP review of the available information and on the basis of a re-evaluation of the benefit risk balance the CHMP is of the opinion that the quality, the safety and the efficacy of Vaniqa continues to be adequately and sufficiently demonstrated and therefore considered the benefit/risk profile of Vaniqa continues to be favourable. However the CHMP has concerns regarding the Phamacovigilance monitoring of Vaniqa by the MAH, in particular related to the low level of reporting of adverse events, the incorrect classification of such events according to System Organ Class and the methodology used to calculate patient exposure. Although the overall risk/benefit remains positive, due to the limited exposure of the product (marketed since August 2004), and the above-mentioned Pharmacovigilance concerns, the CHMP is of the opinion that one additional   |
|---------|-----------------------------------------------------------------------------------|------------|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0019 | IA_09_Deletion of manufacturing site                                              | 09/12/2005 | n/a |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| IA/0018 | IA_05_Change in the name and/or address of a manufacturer of the finished product | 30/09/2005 | n/a |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |

<div style=\"page-break-after: always\"></div>

| N/0017   | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                           | 10/08/2005   | n/a   | PL              |                         |
|----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|-----------------|-------------------------|
| IB/0016  | The MAH applied for Hermal Kurt Herrmann GmbH & Co - Scholtztrasse 3, D-21465 Reinbeck - Germany as an alternative manufacturer responsible for the manufacturing of the dosages form, primary packaging for the finished product, batch Control and testing. IA_08_a_Change in BR/QC testing - repl./add. of batch control/testing site IB_07_c_Replacement/add. of manufacturing site: All other manufacturing operations ex. batch release IB_07_b_02_Replacement/add. of manufacturing | 19/07/2005   | n/a   |                 | site: Primary packaging |
| IB/0014  | IB_10_Minor change in the manufacturing process of the active substance                                                                                                                                                                                                                                                                                                                                                                                                                    | 02/06/2005   | n/a   |                 |                         |
| IA/0015  | IA_07_a_Replacement/add. of manufacturing site: Secondary packaging site                                                                                                                                                                                                                                                                                                                                                                                                                   | 26/05/2005   | n/a   |                 |                         |
| IA/0013  | IA_08_b_01_Change in BR/QC testing - repl./add. manuf. responsible for BR - not incl. BC/testing                                                                                                                                                                                                                                                                                                                                                                                           | 04/03/2005   | n/a   | Annex II and PL |                         |
| IA/0012  | IA_07_a_Replacement/add. of manufacturing site: Secondary packaging site                                                                                                                                                                                                                                                                                                                                                                                                                   | 04/03/2005   | n/a   |                 |                         |
| N/0011   | Further to your letter of Notification received on 7 February 2005 concerning the change in Italian outer                                                                                                                                                                                                                                                                                                                                                                                  | 02/03/2005   | n/a   | Labelling       |                         |

<div style=\"page-break-after: always\"></div>

|         | carton in accordance with article 61(3) of Directive 2001/83/EC, as amended, the EMEA would like to inform you that the change in relation to the addition of the reimbursement price in the blue box area as proposed by Shire Pharmaceutical Contracts Ltd is acceptable. Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)   |            |            |                        |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|
| N/0010  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                               | 06/01/2005 | n/a        | PL                     |
| IB/0009 | IB_42_a_01_Change in shelf-life of finished product - as packaged for sale                                                                                                                                                                                                                                                                                                     | 22/10/2004 | n/a        | SmPC                   |
| IA/0008 | IA_08_a_Change in BR/QC testing - repl./add. of batch control/testing site                                                                                                                                                                                                                                                                                                     | 25/03/2004 | n/a        |                        |
| IA/0007 | IA_08_b_01_Change in BR/QC testing - repl./add. manuf. responsible for BR - not incl. BC/testing                                                                                                                                                                                                                                                                               | 17/03/2004 | n/a        | Annex II and PL        |
| T/0006  | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                            | 22/01/2004 | 04/03/2004 | SmPC, Labelling and PL |
| T/0005  | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                            | 08/07/2003 | 05/08/2003 | SmPC, Labelling and PL |
| I/0004  | 25_Change in test procedures of the medicinal product                                                                                                                                                                                                                                                                                                                          | 21/12/2001 | 11/02/2002 |                        |

<div style=\"page-break-after: always\"></div>

| I/0003   | 03_Change in the name and/or address of the marketing authorisation holder                     | 16/11/2001   | n/a   | SmPC, Labelling and PL   |
|----------|------------------------------------------------------------------------------------------------|--------------|-------|--------------------------|
| I/0002   | 12_Minor change of manufacturing process of the active substance                               | 17/07/2001   | n/a   |                          |
| I/0001   | 11b_Change in supplier of an intermediate compound used in manufacture of the active substance | 24/04/2001   | n/a   |                          |